Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
LBPEC-01 by Locus Biosciences for Escherichia coli Infections: Likelihood of Approval
LBPEC-01 is under clinical development by Locus Biosciences and currently in Phase II for Escherichia coli Infections. According to GlobalData,...